Complement Factor I Polymorphism Is Not Associated with Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in a Chinese Population
Authors:
- Yaoyao SunYSYaoyao Sun
- Zhongtian JinZJZhongtian Jin
- Yong ChengYCYong Cheng
- Shanshan LiSLShanshan Li
- Yujing BaiYBYujing Bai
- Lvzhen HuangLHLvzhen Huang
- Xiaoxin LiXLXiaoxin Li
- 8 April 2014
- journal article
- Published by S. Karger AG in Ophthalmologica
- Vol. 232 (1) , 37-45
Abstract
Purpose: To identify the associations of the two complement factor I (CFI) polymorphisms rs10033900 and rs2285714 with risk of neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) in a Chinese case-control study. Methods: A total of 900 subjects - 300 controls, 300 cases with nAMD and 300 cases with PCV - were included in the present study. Genomic DNA was extracted from venous blood leukocytes. The allelic variants of rs10033900 and rs2285714 were determined by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. The differences in allele distribution between the cases and controls were tested by a χ2 test with age and gender adjusted for by logistic regression analysis. We also performed a meta-analysis of the case-control studies of rs10033900 and rs2285714 based on the currently available evidence from the literature. The meta-analysis was conducted via an inverse-variance, fixed-effects model, as previously described. Results: No statistically significant association was observed between the two polymorphisms of CFI and AMD risk, including nAMD, PCV and combined AMD (p > 0.05 for all comparisons). By meta-analysis, we detected significant associations between both of the SNPs and late AMD, which is consistent with previous results (odds ratio, OR, rs10033900 = 0.814, p rs10033900 < 0.001; OR rs2285714 = 1.221, p rs2285714 < 0.001). For rs2285714, the results of the meta-analysis were less reliable due to its heterogeneity. Conclusions: In our case-control study, neither of the two SNPs most studied (rs10033900 or rs2285714) in the CFI gene was a risk factor for developing nAMD or PCV in a Chinese population. Additional large, comprehensive and well-designed association studies are needed to better understand the role of ethnicity and other gene interactions in the association between the CFI gene and AMD.Keywords
This publication has 29 references indexed in Scilit:
- No evidence of association between complement factor I genetic variant rs10033900 and age-related macular degenerationEuropean Journal of Human Genetics, 2011
- Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degenerationHuman Molecular Genetics, 2011
- Serum Lipid Biomarkers and Hepatic Lipase Gene Associations with Age-Related Macular DegenerationOphthalmology, 2010
- Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degenerationProceedings of the National Academy of Sciences, 2010
- Additional evidence to support the role of a common variant near the complement factor I gene in susceptibility to age-related macular degenerationEuropean Journal of Human Genetics, 2010
- Plasma Complement Components and Activation Fragments: Associations with Age-Related Macular Degeneration Genotypes and PhenotypesInvestigative Ophthalmology & Visual Science, 2009
- Genetic control of the alternative pathway of complement in humans and age-related macular degenerationHuman Molecular Genetics, 2009
- Support for the involvement of complement factor I in age-related macular degenerationEuropean Journal of Human Genetics, 2009
- Variation near complement factor I is associated with risk of advanced AMDEuropean Journal of Human Genetics, 2008
- The role of complement system in ocular diseases including uveitis and macular degenerationMolecular Immunology, 2007